MedTrace Logo

Treat Clozapine ( CLZ )-Resistant Schizophrenia Comparing CLZ + Haloperidol vs. CLZ + Electroconvulsive Therapy (ECT)

NCT00753051 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2012-05-07

No results posted yet for this study

Summary

Clozapine treatment resistant schizophrenia is still prevalent.The effectiveness of augmenting clozapine : one augmenting with haloperidol and the other with electroconvulsive therapy should be determined.This study is a randomized control trial.

Conditions

Interventions

DRUG

clozapine+haloperidol

clozapine 300-900 mg/d haloperidol 4-60 mg/d

DRUG

clozapine,electroconvulsive therapy

clozapine 300-900 mg/d electroconvulsive therapy 4-12 times

Sponsors & Collaborators

  • Khon Kaen University

    lead OTHER

Principal Investigators

  • Suchat Paholpak, MD · Department of Psychiatry.Faculty of Medicine.Khon Kaen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2012-03-31
Completion
2012-05-31

Countries

  • Thailand

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00753051 on ClinicalTrials.gov